PATENT CLAIM ANALYSIS

Application Number: 16356360
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "252030"]

Abstract:
Compounds of Formula 1 as inhibitors of protein tyrosine phosphatase SHP2 are disclosed. The pharmaceutical compositions comprising compounds of Formula 1, methods of synthesis of these compounds, methods of treatment for diseases associated with the aberrant activity of SHP2 such as cancer using these compounds or compositions containing these compounds are also disclosed.

Claim (Index 23):
A method of inhibiting SHP2 activity in a human, having a disease, a disorder, or a condition associated with the aberrant activity of SHP2, comprising administering to the human amount of a compound of  claim 1  that is effective to inhibit SHP2 activity in the human.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 99.0
- Lexical Diversity: 1.58333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15736989', '16228324', '15110511', '15899821', '15736925']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7740584921753868
- 35 USC 102 Novelty (BERT): 0.5219400665439845
- Combined Prediction Score: 0.7488466496122466
- Mean Citation Score: 288.909928
- Max Citation Score: 300.6652200000001
- Similarity Product: 172.56113776133898

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test